Melanoma Clinical Trial

IRIS Registry: Intelligent Research in Sight Registry

Summary

The IRISâ„¢ Registry (Intelligent Research in Sight) is the nation's first comprehensive eye disease clinical registry. The American Academy of Ophthalmology is developing it as part of the profession's shared goal of continual improvement in the delivery of eye care.The IRIS Registry will be a centralized system for ophthalmology practices to promote practice innovations and achieve clinical excellence.

View Full Description

Full Description

The IRIS Registry is primarily a clinical self-improvement tool. It will allow ophthalmologists to compare their patient outcomes, professional performance and care processes against other ophthalmologists across the country. The IRIS Registry will be able to measure the continuum of care from initial patient contact, through intervention and follow up.

Improve Patient Care - Monitor patient interactions, track interventions, identify and address gaps in quality of care, and measure quality outcomes.

Manage Patient Populations - Proactively manage clinical conditions for entire patient populations by running reports on specific care criteria.

Benchmark Your Practice - Identify practice strengths and weaknesses using the IRIS Registry's ophthalmology-specific clinical data from other practices to compare to the performance and outcomes data of your practice.

Run quality reports on demand - Providing clinician- and practice-level results, plus national results and patient-level detail for all IRIS Registry measures.

Enhance Quality and Practice Efficiency - Use the IRIS Registry data to analyze practice processes and procedures and as a source for fact-based decision-making. Because the IRIS Registry will capture data over time at the individual and practice level, it will help practices efficiently manage patient care and optimize practice resources.

Join a Community of Quality - Become a member of a like-minded community of quality-driven professionals striving to continuously improve patient care. Interact with your peers to create opportunities for sharing quality improvement strategies and broaden your professional network.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Patients who meet the denominator requirements for each measure.

Exclusion Criteria:

None

Study is for people with:

Melanoma

Estimated Enrollment:

20000000

Study ID:

NCT02485847

Recruitment Status:

Recruiting

Sponsor:

American Academy of Ophthalmology

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

American Academy of Opthalmology
San Francisco California, 94109, United States More Info
Andy Khuong
Contact
415-561-8500
[email protected]

How clear is this clinincal trial information?

Study is for people with:

Melanoma

Estimated Enrollment:

20000000

Study ID:

NCT02485847

Recruitment Status:

Recruiting

Sponsor:


American Academy of Ophthalmology

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.